Skip to main content

Table 1 Summary examinations of glycogen storage disease type Ib patients at the first visit

From: Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective study

Patient

Sex

Age of onset (months)

Age of diagnosis (months)

Chief complaint

Height

(SD)

Liver size

(cm)

Mutations

GLU (mmol/L)

LAC (mmol/L)

ALT

(U/L)

AST

(U/L)

TG

(mmol/L)

UA

(mmol/L)

NEU

(109/L)

Hb

(g/L)

1

M

7

36

Hepatomegaly

ND

12

c.446G > A/

c.446G > A

1.60

6.20

53

69

8.86

ND

1.21

93

2

M

15

15

Recurrent infection

-3.45

10

c.446G > A/

c.446G > A

3.05

19.60

1100

406

5.65

568

1.68

94

3

F

12

36

Growth retardation

Hepatomegaly

-4.01

4

c.572 C > T/

c.870 + 5G > A

1.30

10.40

363

485

8.66

727

0.51

114

4

F

0

3

Hypoglycemia

ND

9

c.446G > A/ c.446G > A

2.00

4.40

192

409

14.51

462

0.69

97

5

M

2

2

Recurrent infection

ND

6

c.446G > A/ c.446G > A

3.50

3.40

452

1826

6.15

1059

0.30

102

6 a

M

0

4

Recurrent infection

-0.26

10

c.446G > A/

c.959dupT

5.00

12.20

24

90

5.36

268

1.11

77

7

F

7

7

Polypnea for lactic acid

-2.22

10

c.446G > A/ c.446G > A

1.90

10.10

148

238

13.01

786

1.03

84

8

M

6

6

Recurrent infection

Transaminase elevation

-1.83

6

c.343G > A/

c.1042_1043delCT

1.10

8.30

39

65

8.72

228

0.49

97

9

M

11

11

Hepatomegaly

-1.97

5

c.446G > A/

c.446G > A

2.70

3.00

220

232

ND

735

0.68

95

10

F

3

3

Recurrent infection

-0.60

6

c.446G > A/

c.454G > C

0.60

6.40

148

159

5.35

480

0.59

90

11a

F

2

3

Recurrent infection

ND

5

c.446G > A/

c.446G > A

4.00

4.52

37

264

ND

917

1.52

92

12

F

0

7

Abdominal distension

Recurrent infection

-2.20

10

c.446G > A/

c.446G > A

1.90

8.80

542

1951

14.24

170

0.56

90

13 a

F

3

21

Recurrent infection

ND

12

c.446G > A/

c.446G > A

2.35

11.00

79

77

6.21

793

0.74

98

14

F

8

8

Abdominal distension

-2.71

13

c.446G > A/

c.359dupC

1.00

9.80

162

300

4.74

511

0.30

102

15

F

6

6

Abdominal distension

Recurrent infection

-1.35

10

c.446G > A/

c.446G > A

4.27

13.00

172

269

11.62

393

1.38

112

16

F

4

6

Polypnea for lactic acid

-0.67

10

c.82 C > T/

c.359delC

2.30

4.10

80

121

1.84

446

0.52

104

17

F

6

66

Abdominal distension

Recurrent infection

-2.09

5

c.446G > A/

c.446G > A

4.50

2.00

33

40

3.79

660

0.65

84

18

M

7

8

Abdominal distension

-2.92

5

c.446G > A/

c.123_124dupGA

2.23

11.20

206

286

20.37

361

1.96

98

19

M

4

7

Recurrent infection

-1.77

6

c.446G > A/

c.343G > A

1.70

14.80

95

104

4.70

323

1.42

92

20

M

0

47

Abdominal distension

-2.33

10

c.82 C > T/

c.1117G > A

1.92

10.40

39

54

9.20

609

1.04

114

21 a

M

4

4

Polypnea for lactic acid

-0.51

11

c.446G > A/

c.1063G > T

0.50

4.20

339

1456

1.83

370

0.60

102

22

M

12

14

Abdominal distension

-3.42

8

c.446G > A/

c.446G > A

0.70

3.10

66

88

6.77

292

1.09

110

23

M

3

3

Polypnea for lactic acid

-1.13

5

c.446G > A/

c.446G > A

1.60

6.20

76

88

3.51

157

2.09

82

24

M

12

36

Abdominal distension

-1.16

13

c.572 C > T/

c.898 C > T

4.84

3.20

38

42

4.38

513

0.71

101

25 a

M

8

10

Abdominal distension

Hypoglycemia

-2.30

8.5

c.1210delT/

exon5-11 del

2.90

13.60

150

344

2.09

517

0.76

102

26

F

6

8

Polypnea for lactic acid

-2.09

9

c.446G > A/

c.446G > A

4.55

4.90

52

68

6.26

343

0.36

78

27

F

2

3

Polypnea for lactic acid

Recurrent infection

0.52

6

c.1042_1043delCT/c.1123 + 1G > T

1.43

17.20

54

58

6.67

842

0.62

72

28

F

12

31

Abdominal distension

Growth retardation

-4.22

10.5

c.446G > A/

c.870 + 5G > A

1.90

9.60

125

99

9.03

553

0.76

119

29

M

0

7

Polypnea for lactic acid

-2.30

11

c.446G > A/

c.59G > A

3.78

4.07

37

62

3.62

237

0.48

106

30

F

0

2

Recurrent infection

Abdominal distension

-1.62

3

c.446G > A/

c.446G > A

1.96

9.14

116

216

5.01

152

0.65

82

31

F

12

24

Hepatomegaly

-1.16

3

c.446G > A/

c.572 C > T

2.70

11.40

28

27

4.75

459

0.64

105

32

M

1

16

Recurrent infection

Abdominal distension

-2.28

10.5

c.446G > A/

c.870 + 3delG

1.77

15.45

148

135

6.10

603

1.21

103

33

M

1

5

Abdominal distension

-1.49

11

c.446G > A/

c.446G > A

1.38

11.60

40

157

5.28

775

0.27

90

34

F

5

10

Recurrent infection

Hepatomegaly

-3.47

5

c.446G > A/

c.572 C > T

0.53

5.10

251

349

6.58

275

0.77

112

35

M

5

16

Hypoglycemia

Hepatomegaly

-2.17

8

c.446G > A/

c.446G > A

4.84

3.62

21

30

1.94

277

1.20

108

Median

5.0

8.0

 

-2.09

9.0

 

1.96

8.80

95

135

6.10

471

0.71

98

Percentile

(25%,75%)

2.0,7.5

4.5,16.0

 

-1.21,

-2.32

5.5,

10.3

 

1.52, 3.28

4.30, 11.30

40,182

69,293

4.70,8.72

300,647

0.58,1.16

90,105

Reference

      

4.10–5.90

0.90–1.70

7–50

5–60

0.23–1.70

90–420

2.00-7.20

 
  1. GLD, blood glucose; LAC, lactic acid; ALT, alanine transaminase; AST, aspartate aminotransferase; TG, triglyceride; UA, uric acid; NEU, neutrophil count; Hb, hemoglobin; ND, not detected
  2. a, Patients that deceased during the long-term follow-up